These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8186114)

  • 1. Comparative effects of calcipotriol (MC903) solution and placebo (vehicle of MC903) in the treatment of psoriasis of the scalp.
    Green C; Ganpule M; Harris D; Kavanagh G; Kennedy C; Mallett R; Rustin M; Downes N
    Br J Dermatol; 1994 Apr; 130(4):483-7. PubMed ID: 8186114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of calcipotriol solution (50 micrograms/ml) and betamethasone 17-valerate solution (1 mg/ml) in the treatment of scalp psoriasis.
    Klaber MR; Hutchinson PE; Pedvis-Leftick A; Kragballe K; Reunala TL; Van de Kerkhof PC; Johnsson MK; Molin L; Corbett MS; Downess N
    Br J Dermatol; 1994 Nov; 131(5):678-83. PubMed ID: 7999600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.
    Kragballe K; Hoffmann V; Ortonne JP; Tan J; Nordin P; Segaert S
    Br J Dermatol; 2009 Jul; 161(1):159-66. PubMed ID: 19416259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scalp psoriasis: topical calcipotriol 50 micrograms/g/ml solution vs. betamethasone valerate 1% lotion.
    Duweb GA; Abuzariba O; Rahim M; al-Taweel M; Abdulla SA
    Int J Clin Pharmacol Res; 2000; 20(3-4):65-8. PubMed ID: 11314240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of safety and efficacy between calcipotriol plus betamethasone dipropionate gel and calcipotriol scalp solution as long-term treatment for scalp psoriasis in Chinese patients: a national, multicentre, prospective, randomized, active-controlled phase 4 trial.
    Liu L; Zhang C; Wang J; Chen K; Ding Y; Yan G; Lu Q; Li W; Fang H; Cheng H; Zhang J; He Y; Zhu W; Lu Y; Huang J; Pan W; Li M; Cao S; Li S; Han X; He L; Chen Y; Zheng M
    Eur J Dermatol; 2020 Oct; 30(5):580-590. PubMed ID: 33052103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcipotriol solution in scalp psoriasis.
    Duweb G; Alhaddar J; Abuhamida M
    Int J Tissue React; 2005; 27(4):163-6. PubMed ID: 16440580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcipotriol solution for the treatment of scalp psoriasis: evaluation of efficacy, safety and acceptance in 3,396 patients.
    Thaçi D; Daiber W; Boehncke WH; Kaufmann R
    Dermatology; 2001; 203(2):153-6. PubMed ID: 11586015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of betamethasone valerate mousse in comparison with standard therapies on scalp psoriasis: an open, multicentre, randomized, controlled, cross-over study on 241 patients.
    Andreassi L; Giannetti A; Milani M;
    Br J Dermatol; 2003 Jan; 148(1):134-8. PubMed ID: 12534607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of addition of calcipotriol ointment (50 micrograms/g) to acitretin therapy in psoriasis.
    van de Kerkhof PC; Cambazard F; Hutchinson PE; Haneke E; Wong E; Souteyrand P; Damstra RJ; Combemale P; Neumann MH; Chalmers RJ; Olsen L; Revuz J
    Br J Dermatol; 1998 Jan; 138(1):84-9. PubMed ID: 9536227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life in patients with scalp psoriasis treated with calcipotriol/betamethasone dipropionate scalp formulation: a randomized controlled trial.
    Ortonne JP; Ganslandt C; Tan J; Nordin P; Kragballe K; Segaert S
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):919-26. PubMed ID: 19453810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hair root pattern after calcipotriol treatment for scalp psoriasis.
    Kuijpers AL; van Baar HM; van Gasselt MW; van de Kerkhof PC
    Acta Derm Venereol; 1995 Sep; 75(5):388-90. PubMed ID: 8615060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An investigator-masked comparison of the efficacy and safety of twice daily applications of calcitriol 3 microg/g ointment vs. calcipotriol 50 microg/g ointment in subjects with mild to moderate chronic plaque-type psoriasis.
    Zhu X; Wang B; Zhao G; Gu J; Chen Z; Briantais P; Andres P
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):466-72. PubMed ID: 17373972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcipotriol plus betamethasone dipropionate gel compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized, controlled trial investigating efficacy and safety in a Chinese population.
    Ma L; Yang Q; Yang H; Wang G; Zheng M; Hao F; Gu J; Sun Q; Cui P; Ge M; Li R; Gao T; Facy P; Kurvits M; Xu Z; Xu J
    Int J Dermatol; 2016 Jan; 55(1):106-13. PubMed ID: 26094549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter, randomized, double-blind study of the efficacy and safety of calcipotriene foam, 0.005%, vs vehicle foam in the treatment of plaque-type psoriasis of the scalp.
    Feldman SR; Mills M; Brundage T; Eastman WJ
    J Drugs Dermatol; 2013 Mar; 12(3):300-6. PubMed ID: 23545912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Calcipotriol Study Group.
    Molin L; Cutler TP; Helander I; Nyfors B; Downes N
    Br J Dermatol; 1997 Jan; 136(1):89-93. PubMed ID: 9039301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clobetasol propionate shampoo 0.05% and calcipotriol solution 0.005%: a randomized comparison of efficacy and safety in subjects with scalp psoriasis.
    Reygagne P; Mrowietz U; Decroix J; de Waard-van der Spek FB; Acebes LO; Figueiredo A; Caputo R; Poncet M; Arsonnaud S
    J Dermatolog Treat; 2005 Feb; 16(1):31-6. PubMed ID: 15897165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
    van de Kerkhof PC; Hoffmann V; Anstey A; Barnes L; Bolduc C; Reich K; Saari S; Segaert S; Vaillant L
    Br J Dermatol; 2009 Jan; 160(1):170-6. PubMed ID: 19067709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of scalp psoriasis. An effective and safe tacalcitol emulsion].
    Ruzicka T; Trompke C
    Hautarzt; 2004 Feb; 55(2):165-70. PubMed ID: 14968327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study.
    Buckley C; Hoffmann V; Shapiro J; Saari S; Cambazard F; Milsgaard M
    Dermatology; 2008; 217(2):107-13. PubMed ID: 18463448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of calcipotriol (MC 903) ointment in psoriasis vulgaris. A randomized, double-blind, right/left comparative, vehicle-controlled study.
    Dubertret L; Wallach D; Souteyrand P; Perussel M; Kalis B; Meynadier J; Chevrant-Breton J; Beylot C; Bazex JA; Jurgensen HJ
    J Am Acad Dermatol; 1992 Dec; 27(6 Pt 1):983-8. PubMed ID: 1479106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.